NXP Semiconductors, Kyndryl, Clorox: After-Hours Earnings Surprise Market

NXP Semiconductors, Kyndryl, and Clorox have reported their financial results for the fourth quarter and full-year 2024, with mixed outcomes that have left investors with a range of reactions. While NXP and Kyndryl delivered earnings that surpassed expectations, Clorox's results fell short of analyst estimates.

NXP Semiconductors reported quarterly earnings of $3.18 per share, beating the analyst consensus estimate of $3.14. Quarterly revenue came in at $3.11 billion, also surpassing the analyst consensus estimate of $3.104 billion. The company's strong performance was driven by solid execution, consistent gross margin, and healthy free cash flow generation despite a challenging market environment. NXP's President and CEO, Kurt Sievers, attributed the company's resilience to its focus on managing what is in its control while executing its growth strategy.



Kyndryl Holdings, Inc. reported adjusted earnings of $0.51 per share for the third quarter, beating the analyst estimate of $0.41. Revenue for the quarter was $3.744 billion, down from $3.936 billion in the same period last year. Despite the revenue decline, Kyndryl's earnings performance was driven by cost savings and improved gross margin. The company's CEO, Linda Rendle, highlighted the company's strong demand creation plans and the resiliency of its portfolio in the face of market challenges.

Clorox, on the other hand, reported adjusted earnings of $1.55 per share, down from $2.16 in the same period last year. Revenue for the quarter was $1.69 billion, down 15% year-on-year. The company's results were impacted by lapping the impact of retail inventory restoration following the August 2023 cyberattack and the divestitures of the VMS and Argentina businesses. Clorox's CEO, Linda Rendle, acknowledged the challenges faced by the company but emphasized its strong demand creation plans and the resiliency of its portfolio.



In summary, NXP Semiconductors and Kyndryl delivered strong earnings performances, driven by their focus on innovation, cost savings, and strategic acquisitions. Clorox, however, faced challenges due to the impact of the cyberattack and business divestitures. Despite these challenges, the company remains focused on its growth strategy and the resiliency of its portfolio. As investors digest these earnings reports, they will be looking for signs of continued growth and market recovery in the coming quarters.